DnB Asset Management
BLUE

DnB Asset Management’s bluebird bio BLUE Stock Holding History

DnB Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-838
Closed -$470K – 636
2020
Q4 		$470K Buy
838
+58
+7% +$36.8K ﹤0.01% 607
2020
Q3 		$545K Buy
+780
New +$608K 0.01% 580

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DnB Asset Management's BLUE Position: Q1 2021 in Review

DnB Asset Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 838 shares — an estimated $470K sold.

DnB Asset Management first reported a position in BLUE in Q3 2020 and held it in 2 quarters. The position peaked at $545K in Q3 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • DnB Asset Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • DnB Asset Management sold 838 bluebird bio shares in Q1 2021, an estimated $470K.
  • DnB Asset Management first reported a position in bluebird bio in Q3 2020 and held it in 2 quarters.
  • DnB Asset Management's bluebird bio position peaked at $545K in Q3 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on DnB Asset Management's 13F filing for Q1 2021, filed 15 Apr 2021.